BT1769
BT1769 is a MT1-MMP-targeted (KD = 3.35 nM) Bicycle toxin conjugate. BT1769 can be used in the study for osteosarcoma. BT1769 consists of a novel bicyclic targeting peptide that selectively binds MT1-MMP; a cytotoxin MMAE; and an enzymatically cleavable dipeptide linker.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C186H269N43O50S
- Masse moléculaire:3939.45
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
Masse moléculaire 3939.45
-
Formule C186H269N43O50S
-
Sequence
4-Pentynoic acid-βAla-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Ala-Dap(Me)-Ala-Asn-Glu-1Nal-Ala-Cys-Glu-Asp-Phe-Tyr-Asp-Tle-Dap(Me)-NH2(Dap(Me)&Cys bridged with TBMB)(Click with Azidoacetic acid-Val-Cit-PAB-MMAE)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BT1769 Related Classifications
HY-P10775 Related Classifications
Powered by Bioz